3
Views
0
CrossRef citations to date
0
Altmetric
Research

Patent Evaluation Central & Peripheral Nervous Systems: Benzoxazolinone and benzothiazolinone derivatives

Pages 399-401 | Published online: 29 Feb 2008
 

Abstract

This patent describes a series of new benzoxazolinone and benzothiazolinone derivatives that are claimed to interact selectively with sigma (σ) binding sites in the brain. Their in vitro affinities for these binding sites are not disclosed. In vivo, they are active in animal tests commonly used to predict antipsychotic, anxiolytic and antidepressant activity. Surprisingly, they also appear to be active in an animal model of rheumatoid arthritis.

The compounds are undoubtedly of interest in terms of their in vivo pharmacology, either for use in psychiatry or for the treatment of rheumatoid arthritis. However, it is not clear to what extent the activities described are really due to an interaction with σ binding sites.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.